Browse
Submit Data
Databases
API
Help

Dataset Information

3 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Measurement of skin data of hyperpigmentation caused by chemotherapy with pyrimidine fluoride-derived anticancer agent for development of a medical cover foundation

ABSTRACT: Primary outcome(s): 1) Optical properties (absorption and scattering coefficients) 2) Spectral reflectivity 3) Visia (Facial skin condition) 4) Epidermal and dermal water content Appearance-related distress

DISEASE(S): Gastric Cancer, Colorectal Cancer And Esophageal Cancer

PROVIDER: 2638005 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Expression data from skin fibroblasts derived from Setleis Syndrome patients and normal controls

Project description:Setleis Syndrome is a rare type of facial ectodermal dysplasia characterized by an aged leonine appearance with puckered skin about the eyes, absent eyelashes on both lids or multiple rows on the upper lids and none on the lower lids, eyebrows that slant sharply upward laterally, and a rubbery feel of the nose and chin. Some of the patients showed bilateral temporal marks superficially like forceps marks and like the lesions seen in focal facial dermal dysplasia. We have evidence that Setleis Syndrome is caused by nonsense mutations in the gene coding for the small bHLH transcription factor known as TWIST2 in Puerto Rican and Omani patients. We performed expression microarray analysis of RNA samples derived from skin fibroblasts grown from skin biopsies of Setleis Syndrome patients and normal controls in order to identify genes potentially involved in facial development and the pathogenesis of Setleis Syndrome. A total of 4 control and 4 Setleis Syndrome RNA samples were hybridized to U133 plus 2 Affymetrix 3'IVT arrays in the Mount Sinai School of Medicine Microarray Core Facility.

2009-06-11 | E-GEOD-16524 | biostudies-arrayexpress

Expression data from skin fibroblasts derived from Setleis Syndrome patients and normal controls

2009-06-11 | GSE16524 | GEO

Cell cycle progression data on human skin cancer cells with anticancer synthetic peptide LTX-315 treatment.

Project description: Not available

| S-EPMC7118296 | biostudies-literature

Specialised skin cancer library spectral library for use in data independent mass spectrometry

Project description:A specialised spectral ion reference library for use in data independent acquisition mass spectrometry applications for the purposes of skin specific research with a particular focus on melanoma and keratinocytic carcinoma

2021-08-23 | PXD025791 | Pride

Brevinin-1GHd: a novel Hylarana guentheri skin secretion-derived Brevinin-1 type peptide with antimicrobial and anticancer therapeutic potential.

Project description: Not available

| S-EPMC7225409 | biostudies-literature

Docetaxel Skin Exposure and Micronucleation Contributes to Skin Toxicity Caused by CPC634.

Project description: Not available

| S-EPMC8345028 | biostudies-literature

Evaluation for effects on anticancer efficacy and patient’s QOL from dosage adjustment caused by skin toxicity in Panitumumab treatment for Metastatic Colorectal Cancer

Project description:Interventions: mFOLFOX6+Panitumumab therapy is performed until PD. And dosage of Panitumumab is adjusted according to skin toxicity measured by self-check sheet before each therapy. Oxaliplatin 85mg/m2 5FU 400mg/m2 bolus, 2400mg/m2 continuous drip Levofolinate 200mg/m2 Panitumumab 6mg/kg Primary outcome(s): Progression-free survival Study Design: Single arm Non-randomized

| 2630399 | ecrin-mdr-crc

Accuracy of medical billing data against the electronic health record in the measurement of colorectal cancer screening rates.

Project description: Not available

| S-EPMC7103821 | biostudies-literature